TrimRx's Blog
AstraZeneca Obesity Pipeline: What’s Coming
AstraZeneca arrived late to the obesity drug race.
Are Online GLP-1 Programs Safe: 2026 Honest Assessment
Introduction Online GLP-1 programs can be safe when they use state-licensed clinicians, source from registered compounding or retail pharmacies, screen patients for contraindications, and…
AOD-9604: Can You Stack It with GLP-1 Medications?
The question comes up often in peptide forums and clinic intake calls.
AOD-9604 What the Research Actually Says: Evidence Review
AOD-9604 has one of the most lopsided gaps in the peptide world between what marketing copy promises and what the published literature shows.
AOD-9604 How It Works: Mechanism of Action Explained Simply
AOD-9604 is a 16-amino-acid peptide carved out of the tail end of human growth hormone. The name AOD stands for Anti-Obesity Drug.
AOD-9604 Dosing Protocol: Cycling, Frequency & Best Practices
AOD-9604 has no FDA-approved dose because it has no FDA-approved indication.
AOD-9604 Complete Guide: Benefits, Dosing, Side Effects & Research
AOD-9604 is a synthetic peptide built from the last 16 amino acids of the human growth hormone (hGH) molecule (residues 177-191).
What to Do When Anthem Denies Zepbound: Step-by-Step Appeal
Anthem owns 14 Blue Cross Blue Shield licensees and processes pharmacy benefits through CarelonRx (formerly IngenioRx), Anthem’s wholly-owned PBM.
What to Do When Anthem Denies Wegovy: Appeal Strategy
Introduction Anthem owns 14 Blue Cross Blue Shield licensees across the US: California, Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, Nevada, New Hampshire, New…